$11.71Billion | No. of Holdings #84
RTW INVESTMENTS, LP Performance
| Ticker | $ Bought |
|---|---|
| kailera therapeutics inc | 237,413,000 |
| structure therapeutics inc | 86,274,900 |
| axogen inc | 46,724,700 |
| danaher corp del | 43,810,400 |
| solid biosciences inc | 38,890,300 |
| ideaya biosciences inc | 13,803,700 |
| allogene therapeutics inc | 6,760,000 |
| maze therapeutics inc | 6,326,080 |
| Ticker | % Inc. |
|---|---|
| ultragenyx pharmaceutical in | 113 |
| tenax therapeutics inc | 88.14 |
| larimar therapeutics inc | 71.07 |
| oruka therapeutics inc | 52.52 |
| uniqure nv | 52.4 |
| cullinan therapeutics inc | 38.59 |
| definium therapeutics inc | 33.33 |
| irhythm holdings inc | 30.81 |
| Ticker | % Reduced |
|---|---|
| avalo therapeutics inc | -79.58 |
| hinge health inc | -74.09 |
| cogent biosciences inc | -57.7 |
| exagen inc | -50.66 |
| heartflow inc | -40.4 |
| beta bionics inc | -25.00 |
| natera inc | -20.00 |
| taysha gene therapies inc | -0.88 |
| Ticker | $ Sold |
|---|---|
| compass therapeutics inc | -22,147,100 |
| apellis pharmaceuticals inc | -148,249,000 |
| apogee therapeutics inc | -234,169,000 |
| centessa pharmaceuticals plc | -81,591,800 |
| waystar hldg corp | -39,299,300 |
| crinetics pharmaceuticals in | -52,712,200 |
| inventiva sa | -7,207,800 |
| fulgent genetics inc | -20,495,100 |
RTW INVESTMENTS, LP has about 76.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 76.4 |
| Others | 23.6 |
RTW INVESTMENTS, LP has about 21% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 39.3 |
| UNALLOCATED | 23.6 |
| LARGE-CAP | 21 |
| SMALL-CAP | 15.9 |
About 56.6% of the stocks held by RTW INVESTMENTS, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 56.6 |
| Others | 43 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
RTW INVESTMENTS, LP has 84 stocks in it's portfolio. About 47.7% of the portfolio is in top 10 stocks. INSM proved to be the most loss making stock for the portfolio. AGLE was the most profitable stock for RTW INVESTMENTS, LP last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc RTW INVESTMENTS, LP's holding in Acadia Pharmaceuticals Inc over time | 1.54% | 7,144,520 | $180.76M 1.54% | 0%unchanged 0 percentunchanged | |
Spyre Therapeutics Inc RTW INVESTMENTS, LP's holding in Spyre Therapeutics Inc over time | 3.22% | 4,252,000 | $377.49M 3.22% | 1.92%increased 1.92 percentadded | |
Alkermes Plc Alkermes PlcALKS RTW INVESTMENTS, LP's holding in Alkermes Plc over time | 0.75% | 1,672,360 | $87.62M 0.75% | 0%unchanged 0 percentunchanged | |
Allogene Therapeutics Inc RTW INVESTMENTS, LP's holding in Allogene Therapeutics Inc over time | 0.06% | 3,250,000 | $6.76M 0.06% | Newnew position | |
Apellis Pharmaceuticals Inc RTW INVESTMENTS, LP's holding in Apellis Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Aquestive Therapeutics Inc RTW INVESTMENTS, LP's holding in Aquestive Therapeutics Inc over time | 0.26% | 7,426,470 | $30.89M 0.26% | 0%unchanged 0 percentunchanged | |
ARGX Argenx SeArgenx SeARGX | 5.62% | 709,446 | $658.20M 5.62% | 0%unchanged 0 percentunchanged | |
Arrowhead Pharmaceuticals In RTW INVESTMENTS, LP's holding in Arrowhead Pharmaceuticals In over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Jade Biosciences Inc RTW INVESTMENTS, LP's holding in Jade Biosciences Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Avalo Therapeutics Inc RTW INVESTMENTS, LP's holding in Avalo Therapeutics Inc over time | 0.03% | 175,000 | $3.23M 0.03% | 79.58%decreased 79.58 percentreduced | |
Axogen Inc Axogen IncAXGN RTW INVESTMENTS, LP's holding in Axogen Inc over time | 0.4% | 1,011,580 | $46.72M 0.4% | Newnew position | |
Beam Therapeutics Inc RTW INVESTMENTS, LP's holding in Beam Therapeutics Inc over time | 0.17% | 570,394 | $19.58M 0.17% | 0%unchanged 0 percentunchanged | |
BLTE Belite Bio IncBelite Bio IncBLTE | 0.94% | 715,332 | $110.15M 0.94% | 0%unchanged 0 percentunchanged | |
Candel Therapeutics Inc RTW INVESTMENTS, LP's holding in Candel Therapeutics Inc over time | 0.56% | 6,422,020 | $66.15M 0.56% | 0%unchanged 0 percentunchanged | |
Capricor Therapeutics Inc RTW INVESTMENTS, LP's holding in Capricor Therapeutics Inc over time | 0.05% | 250,000 | $6.02M 0.05% | 0%unchanged 0 percentunchanged | |
Celcuity Inc Celcuity IncCELC RTW INVESTMENTS, LP's holding in Celcuity Inc over time | 2.95% | 3,304,900 | $345.76M 2.95% | 8.73%increased 8.73 percentadded | |
Cullinan Therapeutics Inc RTW INVESTMENTS, LP's holding in Cullinan Therapeutics Inc over time | 0.37% | 2,364,350 | $43.05M 0.37% | 38.59%increased 38.59 percentadded | |
CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 1.29% | 10,701,000 | $151.42M 1.29% | 0.65%increased 0.65 percentadded | |
Compass Therapeutics Inc RTW INVESTMENTS, LP's holding in Compass Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Centessa Pharmaceuticals Plc RTW INVESTMENTS, LP's holding in Centessa Pharmaceuticals Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |